CompletedNCT05603819
Clinical Validation Study for EDIT-B Test: an Aid for Differential Diagnosis of Bipolarity, Based on RNA Editing Blood Biomarkers
Observational studyAges 18–80Multiple countries
Understand this study
Who was this study for?
Listed age limits: 18 years to 80 years.
- Listed locations
- Copenhagen and 3 more locationsSee all locations and recruitment
Study information
Study start dateStarted: June 29, 2022
- Recruitment status
- Completed
- Enrollment listed in the registry
- 418
- Sponsor
- Alcediag
- Sponsor type
- Unknown or unclear
- Study type
- Observational
- Intervention type
- DEVICE
- Study phase
- Not clearly listed
- Locations
- France, Denmark, Spain
- Age range
- From 18 Years to 80 Years
- Official registry ID
- NCT05603819
- Official title
Show the full official title
Clinical Validation Study for EDIT-B Test: an Aid for Differential Diagnosis of Bipolar Disorder, Based on RNA Editing Blood Biomarkers
Recruitment & locations
CompletedCopenhagen, Denmark · Paris, France · Sant Boi de Llobregat, Spain
1 more locations
- Barcelona, Spain
Questions about this study
Who is behind this study?
The study sponsor is Alcediag.
Who was this study for?
Listed age limits: 18 years to 80 years.
Want to find a study that may fit you better?
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.
Find a study that may fit me